A previous infection with Toxoplasma gondii does not protect against a challenge with Neospora caninum in pregnant sheep.
Sheep immunized with Toxoplasma gondii (Toxovax) prior to pregnancy were tested for their ability to withstand a challenge at 90 days gestation with 107 Neospora caninum (NC1) tachyzoites. The antibody responses in sheep following immunization with T. gondii were specific for T. gondii whereas peripheral blood mononuclear cells responded to both T. gondii and N. caninum antigen in vitro. This suggested that there was induction of crossreactive immune recognition in the sheep, at least at the cellular level. Following challenge of sheep at mid-gestation with N. caninum, no febrile responses were recorded in the group of sheep which had previously received Toxovax while significant febrile responses were recorded in the group of sheep which received N. caninum challenge alone. Antibody responses to N. caninum developed in all sheep following N. caninum challenge and antibody responses to T. gondii were boosted in the group of sheep which had previously been immunized with Toxovax. No antibodies to T. gondii were observed in the sheep which received the N. caninum challenge alone. Peripheral blood mononuclear cells from both groups of sheep responded to T. gondii and N. caninum antigen in vitro and interferon gamma was present in the cell-free supernatant from activated cells. However despite evidence of the induction of crossreactive immunity between T. gondii and N. caninum, this was not sufficient to prevent foetal death. The group of sheep which had received Toxovax prior to pregnancy and the group of sheep which only received the N. caninum challenge experienced 100% foetal death compared with 0% in the unchallenged control group. Vaccination prior to pregnancy with Toxovax did protect against foetal death following oral challenge at 90 days with 2000 T. gondii oocysts which caused 100% foetal death in a control challenge group.
Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Edinburgh, UK. inne1@mri.sari.ac.uk
E A
EA
Innes
A
A
Lundén
I
I
Esteban
J
J
Marks
S
S
Maley
S
S
Wright
A
A
Rae
D
D
Harkins
A
A
Vermeulen
I J
IJ
McKendrick
D
D
Buxton
D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology; D002455:Cell Division; D003048:Coccidiosis / Q000469:parasitology / Q000473:pathology / Q000517:prevention & control*; D016054:DNA, Protozoan / Q000032:analysis; D005260:Female; D007371:Interferon-gamma / Q000276:immunology; D018688:Neospora / Q000235:genetics / Q000276:immunology*; D016133:Polymerase Chain Reaction / Q000379:methods; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000469:parasitology / Q000473:pathology / Q000517:prevention & control*; D011256:Pregnancy Outcome; D011270:Pregnancy, Animal; D012756:Sheep; D013696:Temperature; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000276:immunology*
D000913:Antibodies, Protozoan; D016054:DNA, Protozoan; D007371:Interferon-gamma